Decitabine in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of decitabine in treating
patients with advanced solid tumors that have not responded to previous treatment. Drugs used
in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die